Your browser doesn't support javascript.
loading
Harmonization of Busulfan Plasma Exposure Unit (BPEU): A Community-Initiated Consensus Statement.
McCune, Jeannine S; Quinones, Christine M; Ritchie, James; Carpenter, Paul A; van Maarseveen, Erik; Yeh, Rosa F; Anasetti, Claudio; Boelens, Jaap J; Hamerschlak, Nelson; Hassan, Moustapha; Kang, Hyoung Jin; Kanda, Yoshinobu; Paci, Angelo; Perales, Miguel-Angel; Shaw, Peter J; Seewaldt, Victoria L; Savani, Bipin N; Hsieh, Angela; Poon, Betsy; Mohty, Mohamad; Pulsipher, Michael A; Pasquini, Marcelo; Dupuis, L Lee.
Afiliação
  • McCune JS; Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Pharmaceutics, University of Washington, Seattle, WA, USA; Molecular Prevention, Intervention and Technology Division, Beckman Research Institute, City of Hope, Duarte, CA, USA. Electronic address: jmccune@coh.org.
  • Quinones CM; Molecular Prevention, Intervention and Technology Division, Beckman Research Institute at City of Hope, Duarte, CA, USA.
  • Ritchie J; Pathology & Laboratory Medicine Department, Emory University, Atlanta, GA, USA.
  • Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Research Center and Department of Pharmaceutics, University of Washington, Seattle, WA, USA.
  • van Maarseveen E; Clinical Pharmacology, University Medical Center Utrecht, Utrecht, Princess Maxima Center for Pediatric Oncology, Utrecht and Drug Analysis and Toxicology division (KKGT) of the Dutch Foundation for Quality Assessment in Medical Laboratories (SKML), Utrecht, Netherlands.
  • Yeh RF; Pharmacokinetics Laboratory, Seattle Cancer Care Alliance, Seattle, WA, USA.
  • Anasetti C; Department of Blood and Marrow Transplant, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA; Molecular Prevention, Intervention and Technology Division, Beckman Research Institute, City of Hope, Duarte, CA, USA.
  • Boelens JJ; Pediatric Blood and Marrow Transplantation Program, University Medical Center Utrecht, Utrecht, Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands; Stem Cell Transplantation and Cellular Therapies, MSK Kids, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Hamerschlak N; Hematology and Bone Marrow Transplantation Department, Hospital Israelita Albert Einstein, São Paulo Area, Brazil.
  • Hassan M; Division of Experimental Cancer Medicine, Department of Laboratory Medicine at Karolinska Institutet and Division of Clinical Research Centrum at Karolinska University Hospital, Stockholm, Sweden.
  • Kang HJ; Department of Pediatrics, Seoul National Univeristy College of Medicine, Seoul National University Cancer Research Institute, Seoul National University Children's Hospital, Seoul, Korea.
  • Kanda Y; Division of Hematology, Department of Medicine, Jichi Medical University and Division of Hematology, Saitama Medical Center, Jichi Medical University, Japan.
  • Paci A; Department of Pharmacology, Institute Gustave Roussy Cancer Center, Grand Paris, School of Pharmacy - Paris Sud University, France.
  • Perales MA; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center and Department of Medicine, Weill Cornell Medical College New York, NY, USA.
  • Shaw PJ; BMT Services, The Children's Hospital at Westmead, Westmead, New South Wales, and Discipline of Child and Adolescent Health, University of Sydney, Australia.
  • Seewaldt VL; Molecular Prevention, Intervention and Technology Division, Beckman Research Institute at City of Hope, Duarte, CA, USA.
  • Savani BN; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Hsieh A; Medical Content Manager at McKesson Specialty Health, Seattle, WA, USA.
  • Poon B; Department of Pharmacy, AdventHealth for Children, Orlando, FL, USA.
  • Mohty M; Department of Hematology and Cell Therapy, Acute Leukemia Working Party EBMT Paris Office, Hôpital Saint-Antoine, Paris, France.
  • Pulsipher MA; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, CA, USA.
  • Pasquini M; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Dupuis LL; Department of Pharmacy and Research Institute, The Hospital for Sick Children and Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada.
Biol Blood Marrow Transplant ; 25(9): 1890-1897, 2019 09.
Article em En | MEDLINE | ID: mdl-31136799
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bussulfano / Sistema de Registros / Bases de Dados Factuais / Monitoramento de Medicamentos / Transplante de Células-Tronco Hematopoéticas / Consenso Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bussulfano / Sistema de Registros / Bases de Dados Factuais / Monitoramento de Medicamentos / Transplante de Células-Tronco Hematopoéticas / Consenso Tipo de estudo: Guideline / Prognostic_studies Limite: Female / Humans / Male Idioma: En Revista: Biol Blood Marrow Transplant Assunto da revista: HEMATOLOGIA / TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos